Keith R. Leonard

Keith R. Leonard (board member) discloses dealings in 6 companies, chiefly Kythera Biopharmaceuticals Inc, Intuitive Surgical Inc and Arcutis Biotherapeutics, Inc. We count 132 filings; the first trade dates from 16 October 2012 and the latest from 5 June 2026.

In open-market terms, that means 2 purchases worth €432k on one side and 78 sales worth €12.6M on the other. Taken together, the sales exceed the purchases by €12.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 10 share grants and 22 option exercises. Since January 2026: no purchases and 1 sale on the market.

The latest filing, published on 9 June 2026, reports a share grant in Arcutis Biotherapeutics, Inc. The most recent open-market purchase was published on 26 February 2019, 2,812 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.